Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution

Completed · Phase 2

Conditions studied: Glaucoma Open-angle

In brief

This is a randomized trial comparing two elution doses of the Travoprost Intraocular implant to timolol ophthalmic solution.

Key facts

Study ID

NCT02754596

Run by

Glaukos Corporation

People needed

154

Starts

2016-03-29

Expected to finish

2020-07-21

Last updated by the study team

2023-09-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Open angle glaucoma

You may not qualify if…

• Uveitic, neovascular, or angle closure glaucoma; or glaucoma associated with vascular disorders.
• Functionally significant visual field loss, including severe nerve fiber bundle defects.
• Prior glaucoma surgery.
• Uncontrolled systemic disease, pregnant females or those planning a pregnancy.
• Other ocular status conditions, etc.

Where it is running

• John Berdahl, MD — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.